Neuralink, Supported by Elon Musk, Secures $280 Million Funding for Brain Interface Advancements

Elon Musk-backed biotech firm Neuralink has announced a successful Series D funding round, raising $280 million, with Peter Thiel’s Founders Fund leading the investment charge. 

The firm, co-founded by Musk in 2016. Focuses on implantable brain-computer interfaces (BCIs) that facilitate direct communication between the brain and external devices. While the specific use of the funds remains undisclosed. Neuralink’s overarching goal is to empower individuals with paralysis or neurological conditions to regain independence through brain-controlled computer and mobile device interaction. 

Despite progress, the company has faced scrutiny for animal testing procedures. Prompting calls for investigations into conflicts of interest. Having recently obtained FDA approval for human clinical trials. Neuralink advances its vision to revolutionize the interface between technology and the human brain

Clever Robot News Desk 8^th August 2023